Precigen (PGEN) Sales of Property, Plant and Equipment (2012 - 2024)

Precigen (PGEN) Sales of Property, Plant and Equipment (2012 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27,000.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Precigen 1.95 Bn 1.95 Bn 20.69 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 57,000.00
Sep 30, 2024 57,000.00
Mar 31, 2024 3,000.00
Mar 31, 2024 3,000.00
Dec 31, 2023 37,000.00
Dec 31, 2023 37,000.00
Jun 30, 2023 61,000.00
Jun 30, 2023 61,000.00
Sep 30, 2022 156,000.00
Sep 30, 2022 156,000.00
Jun 30, 2022 291,000.00
Jun 30, 2022 291,000.00
Mar 31, 2022 147,000.00
Mar 31, 2022 147,000.00
Dec 31, 2021 469,000.00
Dec 31, 2021 469,000.00
Sep 30, 2021 279,000.00
Sep 30, 2021 279,000.00
Jun 30, 2021 314,000.00
Jun 30, 2021 314,000.00